These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 26431226)

  • 21. Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type 1 diabetes.
    Aanstoot HJ; Kang SM; Kim J; Lindsay LA; Roll U; Knip M; Atkinson M; Mose-Larsen P; Fey S; Ludvigsson J; Landin L; Bruining J; Maclaren N; Akerblom HK; Baekkeskov S
    J Clin Invest; 1996 Jun; 97(12):2772-83. PubMed ID: 8675688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of an immunomagnetic bead-based time-resolved fluorescence immunoassay for rapid determination of levels of carcinoembryonic antigen in human serum.
    Hou JY; Liu TC; Lin GF; Li ZX; Zou LP; Li M; Wu YS
    Anal Chim Acta; 2012 Jul; 734():93-8. PubMed ID: 22704477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3 Screen islet cell autoantibody ELISA: A sensitive and specific ELISA for the combined measurement of autoantibodies to GAD
    Amoroso M; Achenbach P; Powell M; Coles R; Chlebowska M; Carr L; Furmaniak J; Scholz M; Bonifacio E; Ziegler AG; Rees Smith B
    Clin Chim Acta; 2016 Nov; 462():60-64. PubMed ID: 27570064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
    Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of immunoassays for the detection of anti-GAD65 autoantibodies in patients with diabetes mellitus.
    Pfützner A; Harzer O; Kunt T; Forst T; Abdollahnia N; Löbig M; Krauss H; Engelbach M; Kann P; Beyer J
    Clin Lab; 2000; 46(5-6):275-9. PubMed ID: 10853236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. XIAP inhibition of β-cell apoptosis reduces the number of islets required to restore euglycemia in a syngeneic islet transplantation model.
    Plesner A; Soukhatcheva G; Korneluk RG; Verchere CB
    Islets; 2010; 2(1):18-23. PubMed ID: 21099289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radioimmunoassay for glutamic acid decarboxylase-65.
    Hao W; Daniels T; Pipeleers DG; Smismans A; Reijonen H; Nepom GT; Lernmark A
    Diabetes Technol Ther; 1999; 1(1):13-20. PubMed ID: 11475299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a dual-label time-resolved fluoroimmunoassay for the detection of α-fetoprotein and hepatitis B virus surface antigen.
    Lin GF; Liu TC; Zou LP; Hou JY; Wu YS
    Luminescence; 2013; 28(3):401-6. PubMed ID: 22715159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects.
    Oling V; Marttila J; Ilonen J; Kwok WW; Nepom G; Knip M; Simell O; Reijonen H
    J Autoimmun; 2005 Nov; 25(3):235-43. PubMed ID: 16263242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Time-resolved fluoroimmunoassay of carcino-embryonic antigen and preparation of its diagnostic reagent].
    Hang JF; Wu YS; Yu WH; Huang Y; Li M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jan; 22(1):121-4. PubMed ID: 16388762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microchip-based engineering of super-pancreatic islets supported by adipose-derived stem cells.
    Jun Y; Kang AR; Lee JS; Park SJ; Lee DY; Moon SH; Lee SH
    Biomaterials; 2014 Jun; 35(17):4815-26. PubMed ID: 24636217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for allograft rejection in an islet transplant recipient and effect on beta-cell secretory capacity.
    Rickels MR; Kamoun M; Kearns J; Markmann JF; Naji A
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2410-4. PubMed ID: 17488791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.
    Pop SM; Wong CP; He Q; Wang Y; Wallet MA; Goudy KS; Tisch R
    Diabetes; 2007 May; 56(5):1395-402. PubMed ID: 17317763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential of UCHL1 as biomarker for destruction of pancreatic beta cells.
    Brackeva B; De Punt V; Kramer G; Costa O; Verhaeghen K; Stangé G; Sadones J; Xavier C; Aerts JM; Gorus FK; Martens GA
    J Proteomics; 2015 Mar; 117():156-67. PubMed ID: 25638021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble Tim3 detection by time-resolved fluorescence immunoassay and its application in membranous nephropathy.
    Chen M; Wang L; Wang Y; Zhou X; Liu X; Chen H; Huang B; Hu Z
    J Clin Lab Anal; 2020 Jun; 34(6):e23248. PubMed ID: 32077157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral T cell clones from NOD mice specific for GAD65 peptides: lack of islet responsiveness or diabetogenicity.
    Schloot NC; Daniel D; Norbury-Glaser M; Wegmann DR
    J Autoimmun; 1996 Jun; 9(3):357-63. PubMed ID: 8816971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A monoclonal antibody based enzyme-linked immunosorbent assay for the determination of GAD65, the smaller isoform of glutamic acid decarboxylase.
    Hamann J; Hahmann J; Strebelow M; Ziegler B; Ziegler M
    Diabetes Res; 1994; 26(3):109-16. PubMed ID: 7621617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
    Fändrich F; Ungefroren H
    Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus.
    Davison LJ; Weenink SM; Christie MR; Herrtage ME; Catchpole B
    Vet Immunol Immunopathol; 2008 Nov; 126(1-2):83-90. PubMed ID: 18706702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential of protein phosphatase inhibitor 1 as biomarker of pancreatic β-cell injury in vitro and in vivo.
    Jiang L; Brackeva B; Ling Z; Kramer G; Aerts JM; Schuit F; Keymeulen B; Pipeleers D; Gorus F; Martens GA
    Diabetes; 2013 Aug; 62(8):2683-8. PubMed ID: 23557701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.